PL2252302T3 - Kompozycja do leczenia zapalenia kości i stawów - Google Patents

Kompozycja do leczenia zapalenia kości i stawów

Info

Publication number
PL2252302T3
PL2252302T3 PL08868336T PL08868336T PL2252302T3 PL 2252302 T3 PL2252302 T3 PL 2252302T3 PL 08868336 T PL08868336 T PL 08868336T PL 08868336 T PL08868336 T PL 08868336T PL 2252302 T3 PL2252302 T3 PL 2252302T3
Authority
PL
Poland
Prior art keywords
osteoarthritis
treatment
composition
Prior art date
Application number
PL08868336T
Other languages
English (en)
Inventor
Ferrer Josep Escaich
Gibert Ana Maria Torrent
Roura Ramon Ruhi
Castañares Pere Dalmau
Original Assignee
Bioiberica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioiberica filed Critical Bioiberica
Publication of PL2252302T3 publication Critical patent/PL2252302T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
PL08868336T 2007-12-28 2008-12-17 Kompozycja do leczenia zapalenia kości i stawów PL2252302T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200703459A ES2325392B1 (es) 2007-12-28 2007-12-28 Composicion para el tratamiento de la artrosis.
EP08868336.2A EP2252302B1 (en) 2007-12-28 2008-12-17 Composition for the treatment of osteoarthritis
PCT/EP2008/067683 WO2009083444A1 (en) 2007-12-28 2008-12-17 Composition for the treatment of osteoarthritis

Publications (1)

Publication Number Publication Date
PL2252302T3 true PL2252302T3 (pl) 2014-05-30

Family

ID=40325780

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08868336T PL2252302T3 (pl) 2007-12-28 2008-12-17 Kompozycja do leczenia zapalenia kości i stawów

Country Status (8)

Country Link
US (1) US8445462B2 (pl)
EP (2) EP2252302B1 (pl)
JP (1) JP2011507930A (pl)
AU (1) AU2008342713A1 (pl)
CA (1) CA2708399A1 (pl)
ES (2) ES2325392B1 (pl)
PL (1) PL2252302T3 (pl)
WO (1) WO2009083444A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190140654A (ko) * 2018-06-12 2019-12-20 주식회사 비알팜 Dna 단편 혼합물 및 매트릭스 메탈로프로테아제 생성 억제제를 포함하는 관절염 예방 및 치료용 조성물
CN117137924A (zh) * 2023-09-28 2023-12-01 宜兴食品与生物技术研究院有限公司 N-乙酰-d-甘露糖胺在制备促进骨生长的食品及药物中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3895106A (en) 1970-04-15 1975-07-15 Morrison L M Novel CSA and CSC for use in man and mammals to inhibit atherosclerosis and the recurrence of cardiovascular incidents in atherosclerotic mammals
ES8605285A1 (es) 1985-10-10 1986-03-16 Bioiberica Procedimiento de obtencion de sal sodica del acido condroitin sulfurico.
US5364845C1 (en) 1993-03-31 2002-09-10 Nutramax Lab Inc Glusosamine chondroitin and manganese composition for the protection and repair of connective tissue
US20070141181A1 (en) * 1998-02-13 2007-06-21 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
AU5339699A (en) 1998-08-06 2000-02-28 Johns Hopkins University School Of Medicine, The Compounds for altering cell surface sialic acids and methods of use therefor
ES2239582T3 (es) * 2000-01-20 2005-10-01 Innovet Italia S.R.L. Una composicion para tratar enfermedades articulares degenerativas.
JP4754066B2 (ja) * 2000-12-22 2011-08-24 株式会社林原生物化学研究所 抗関節障害剤
WO2003002125A2 (en) * 2001-06-29 2003-01-09 Astion A/S Combination of aminosugars and cysteine or cysteine derivatives
ES2223291B1 (es) 2003-08-06 2006-03-16 Bioiberica, S.A. Nuevo uso terapeutico de condroitin sulfato.
US8956677B2 (en) * 2005-11-23 2015-02-17 The Coca-Cola Company High-potency sweetener composition with glucosamine and compositions sweetened therewith
JP2007161688A (ja) 2005-12-16 2007-06-28 Hiroshima Univ 軟骨生成促進剤
WO2007104576A1 (de) 2006-03-16 2007-09-20 Mosetter, Kurt Arzneimittel enthaltend n-acetyl-mannosamin oder derivate hiervon und seine verwendung

Also Published As

Publication number Publication date
EP2301554A8 (en) 2011-10-26
JP2011507930A (ja) 2011-03-10
EP2252302B1 (en) 2013-12-11
ES2325392B1 (es) 2010-06-24
WO2009083444A1 (en) 2009-07-09
US8445462B2 (en) 2013-05-21
US20100286086A1 (en) 2010-11-11
ES2449071T3 (es) 2014-03-18
EP2252302A1 (en) 2010-11-24
AU2008342713A1 (en) 2009-07-09
EP2301554A1 (en) 2011-03-30
CA2708399A1 (en) 2009-07-09
ES2325392A1 (es) 2009-09-02

Similar Documents

Publication Publication Date Title
HK1256861A1 (zh) 用於治療胃腸道炎症的組合物
ZA200902374B (en) Compositions useful for the treatment of diabetes
PL1975226T3 (pl) Płynna kompozycja do obróbki
HK1141013A1 (en) Process for the preparation of certain substituted sulfilimines
HUE043569T2 (hu) Vegyületek rák kezelésére
ZA200907191B (en) Process for the preparation of gefitiib
ZA201003425B (en) 5-cyano-thienopyridines for the treatment of tumors
HK1226938A1 (zh) 骨關節炎治療
EG26571A (en) Its composition consists of a treatment component and a carrier for water treatment
IL210066A0 (en) Novel ortho-aminoanilides for the treatment of cancer
EP2174956A4 (en) COMPOSITIONS FOR ANTIFIBRINOLYSIS THERAPY
IL208624A0 (en) Compositions for the treatment of lice
GB0723100D0 (en) Treatment of HFnEF
PL2252302T3 (pl) Kompozycja do leczenia zapalenia kości i stawów
IL184620A0 (en) Composition for the treatment of inflammation
ZA201001594B (en) Vaccine for the treatment of osteoarthritis
GB0719613D0 (en) The treatment of pruritis
HK1140145A1 (en) Compositions for contributing to the treatment of cancers
GB0700578D0 (en) Composition for treating blood conditions
IL210519A0 (en) Anti-phthiraptera treatment compositions
AU2007902293A0 (en) Water Treatment Composition
GB0621474D0 (en) Composition for the treatment of halitosis
GB0700579D0 (en) Composition for treating stomach conditions
GB0809319D0 (en) The treatment of puritus